4//SEC Filing
BINDER BRANT 4
Accession 0001140361-23-034995
CIK 0000748592other
Filed
Jul 17, 8:00 PM ET
Accepted
Jul 18, 4:15 PM ET
Size
8.2 KB
Accession
0001140361-23-034995
Insider Transaction Report
Form 4
BINDER BRANT
Other
Transactions
- Purchase
6.0% Senior Convertible Promissory Notes due 2028
2023-07-13$120000.00/shExercise: $2.86From: 2023-07-14Exp: 2028-07-14→ Common Stock (41,958 underlying) - Purchase
Warrants (right to buy)
2023-07-13$0.13/sh+83,916$10,490→ 83,916 totalExercise: $2.61From: 2023-07-14Exp: 2028-07-14→ Common Stock (83,916 underlying)
Footnotes (1)
- [F1]The reporting person entered into a Securities Purchase Agreement with the Issuer on July 13, 2023, pursuant to which, on July 14, 2023, the reporting person acquired $120,000 principal amount of the Issuer's 6.0% Senior Convertible Promissory Notes due July 2028 (the "Notes") and (ii) 83,916 warrants, each exercisable to purchase one share of the Company's common stock, par value $0.005 per share ("Common Stock"), at an exercise price of $2.61 per share (the "Warrants"), representing 200% of the number of shares of Common Stock issuable upon conversion of the Notes immediately after the issuance thereof. The conversion price for each Note included $0.25 ($0.125 for each Warrant share) in accordance with Nasdaq rules.
Documents
Issuer
Eterna Therapeutics Inc.
CIK 0000748592
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001133594
Filing Metadata
- Form type
- 4
- Filed
- Jul 17, 8:00 PM ET
- Accepted
- Jul 18, 4:15 PM ET
- Size
- 8.2 KB